Lexington Hill Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Lexington Hill Partners's LLY Position: Q2 2026 in Review
Lexington Hill Partners reduced its Eli Lilly (LLY) stake by 2.8% in Q2 2026, selling an estimated $16.3K and leaving 550 shares worth $660K. The position accounts for 0.32% of the portfolio, ranked #36.
Lexington Hill Partners first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Lexington Hill Partners held 550 shares of Eli Lilly worth $660K as of Q2 2026.
- Lexington Hill Partners sold 16 Eli Lilly shares in Q2 2026, an estimated $16.3K.
- Eli Lilly made up 0.32% of Lexington Hill Partners's portfolio in Q2 2026, its #36 holding.
- Lexington Hill Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
- 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Lexington Hill Partners's 13F filing for Q2 2026, filed 8 Jul 2026.